Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
2,534,263
-
Total 13F shares
-
32,845,333
-
Share change
-
-2,976,128
-
Total reported value
-
$27,285,673
-
Put/Call ratio
-
118%
-
Price per share
-
$0.83
-
Number of holders
-
59
-
Value change
-
-$2,629,911
-
Number of buys
-
30
-
Number of sells
-
38
Institutional Holders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) as of Q2 2023
As of 30 Jun 2023,
Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,845,333 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), UBS Group AG, ARCH Venture Management, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, COATUE MANAGEMENT LLC, Casdin Capital, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, and BlackRock Inc..
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.